Literature DB >> 15929035

Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia.

Chris Zarow1, Harry V Vinters, William G Ellis, Michael W Weiner, Dan Mungas, Lon White, Helena C Chui.   

Abstract

The cornu ammonis 1 region of the hippocampus (CA1) sector of hippocampus is vulnerable to both Alzheimer's disease (AD)-type neurofibrillary degeneration and anoxia-ischemia. The objective of this article is to compare number and size of neurons in CA1 in AD versus ischemic vascular dementia. Unbiased stereological methods were used to estimate the number and volume of neurons in 28 autopsy-derived brain samples. For each case, the entire hippocampus from one cerebral hemisphere was sliced into 5mm slabs (5-7 slabs/case), cut into 50 microm sections, and stained with gallocyanine. Using the optical dissector, we systematically sampled the number and size of neurons throughout the extent of CA1 and CA2. The total number of neurons was significantly less in AD compared with ischemic vascular dementia (p < 0.02), but there was no significant difference in neuron size. The greatest loss of neurons was observed in two cases with combined AD and hippocampal sclerosis. Regardless of causative diagnosis, the number of CA1 neurons correlates with magnetic resonance imaging-derived hippocampal volume (r = 0.72; p < 0.001) and memory score (r = 0.62; p < 0.01). We conclude that although CA1 neuron loss is more consistently observed in AD than ischemic vascular dementia, severity of loss shows the expected correlation with structure and function across causative subtype. Reductions in magnetic resonance imaging-derived hippocampal volume reflect loss, rather than shrinkage, of CA1 neurons.

Entities:  

Mesh:

Year:  2005        PMID: 15929035      PMCID: PMC1851673          DOI: 10.1002/ana.20503

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  23 in total

Review 1.  Structural magnetic resonance imaging in established and prodromal Alzheimer disease: a review.

Authors:  Monika Atiya; Bradley T Hyman; Marilyn S Albert; Ronald Killiany
Journal:  Alzheimer Dis Assoc Disord       Date:  2003 Jul-Sep       Impact factor: 2.703

2.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

3.  A standardized method for brain-cutting suitable for both stereology and MRI-brain co-registration.

Authors:  C Zarow; T-S Kim; M Singh; H C Chui
Journal:  J Neurosci Methods       Date:  2004-10-30       Impact factor: 2.390

4.  Pathological markers associated with normal aging and dementia in the elderly.

Authors:  H A Crystal; D W Dickson; M J Sliwinski; R B Lipton; E Grober; H Marks-Nelson; P Antis
Journal:  Ann Neurol       Date:  1993-10       Impact factor: 10.422

Review 5.  New stereological methods for counting neurons.

Authors:  M J West
Journal:  Neurobiol Aging       Date:  1993 Jul-Aug       Impact factor: 4.673

6.  Unbiased stereological estimation of the number of neurons in the human hippocampus.

Authors:  M J West; H J Gundersen
Journal:  J Comp Neurol       Date:  1990-06-01       Impact factor: 3.215

Review 7.  Staging of Alzheimer-related cortical destruction.

Authors:  H Braak; E Braak; J Bohl
Journal:  Eur Neurol       Date:  1993       Impact factor: 1.710

8.  Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study.

Authors:  J P Vonsattel; R H Myers; E T Hedley-Whyte; A H Ropper; E D Bird; E P Richardson
Journal:  Ann Neurol       Date:  1991-11       Impact factor: 10.422

9.  Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease.

Authors:  M J West; P D Coleman; D G Flood; J C Troncoso
Journal:  Lancet       Date:  1994-09-17       Impact factor: 79.321

10.  No evidence for loss of hippocampal neurons in non-Alzheimer dementia patients.

Authors:  L Korbo; I Amrein; H-P Lipp; D Wolfer; L Regeur; S Oster; B Pakkenberg
Journal:  Acta Neurol Scand       Date:  2004-02       Impact factor: 3.209

View more
  91 in total

1.  3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects.

Authors:  Liana G Apostolova; Kristy S Hwang; John P Andrawis; Amity E Green; Sona Babakchanian; Jonathan H Morra; Jeffrey L Cummings; Arthur W Toga; John Q Trojanowski; Leslie M Shaw; Clifford R Jack; Ronald C Petersen; Paul S Aisen; William J Jagust; Robert A Koeppe; Chester A Mathis; Michael W Weiner; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2010-06-11       Impact factor: 4.673

2.  The dynamics of Alzheimer's disease biomarkers in the Alzheimer's Disease Neuroimaging Initiative cohort.

Authors:  A Caroli; G B Frisoni
Journal:  Neurobiol Aging       Date:  2010-06-11       Impact factor: 4.673

Review 3.  Alliance for aging research AD biomarkers work group: structural MRI.

Authors:  Clifford R Jack
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

4.  Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND.

Authors:  Prashanthi Vemuri; Gyorgy Simon; Kejal Kantarci; Jennifer L Whitwell; Matthew L Senjem; Scott A Przybelski; Jeffrey L Gunter; Keith A Josephs; David S Knopman; Bradley F Boeve; Tanis J Ferman; Dennis W Dickson; Joseph E Parisi; Ronald C Petersen; Clifford R Jack
Journal:  Neuroimage       Date:  2010-12-31       Impact factor: 6.556

5.  Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.

Authors:  Anja Soldan; Corinne Pettigrew; Yi Lu; Mei-Cheng Wang; Ola Selnes; Marilyn Albert; Timothy Brown; J Tilak Ratnanather; Laurent Younes; Michael I Miller
Journal:  Hum Brain Mapp       Date:  2015-04-16       Impact factor: 5.038

6.  Multimodality imaging characteristics of dementia with Lewy bodies.

Authors:  Kejal Kantarci; Val J Lowe; Bradley F Boeve; Stephen D Weigand; Matthew L Senjem; Scott A Przybelski; Dennis W Dickson; Joseph E Parisi; David S Knopman; Glenn E Smith; Tanis J Ferman; Ronald C Petersen; Clifford R Jack
Journal:  Neurobiol Aging       Date:  2011-10-21       Impact factor: 4.673

7.  MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.

Authors:  P Vemuri; H J Wiste; S D Weigand; L M Shaw; J Q Trojanowski; M W Weiner; D S Knopman; R C Petersen; C R Jack
Journal:  Neurology       Date:  2009-07-28       Impact factor: 9.910

8.  MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations.

Authors:  P Vemuri; H J Wiste; S D Weigand; L M Shaw; J Q Trojanowski; M W Weiner; D S Knopman; R C Petersen; C R Jack
Journal:  Neurology       Date:  2009-07-28       Impact factor: 9.910

9.  Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects.

Authors:  Liana G Apostolova; Jonathan H Morra; Amity E Green; Kristy S Hwang; Christina Avedissian; Ellen Woo; Jeffrey L Cummings; Arthur W Toga; Clifford R Jack; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2010-01-18       Impact factor: 6.556

Review 10.  Proton MRS in mild cognitive impairment.

Authors:  Kejal Kantarci
Journal:  J Magn Reson Imaging       Date:  2013-04       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.